Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02042157
Other study ID # IRB-22588
Secondary ID
Status Terminated
Phase N/A
First received January 17, 2014
Last updated October 17, 2017
Start date January 1, 2015
Est. completion date December 31, 2016

Study information

Verified date October 2017
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our expectations (hypotheses) are:

Primary outcome

1. Regular bidet use will improve quality of life around elimination in adults with impaired functional status. Functional status will be measured by activities of daily living (ADL).

2. Regular bidet use by adults with impaired functional status will improve the quality of life around toileting for their caregivers.

Secondary

3. Regular bidet use will reduce the incidence, frequency and severity of constipation (as measured by self-report) in adults with impaired functional status.

4. Regular bidet use will reduce the incidence of urinary tract infection (UTI) in adult women with impaired functional status.


Description:

The study will assess the use of a bidet (a device that is attached to the toilet which allows a person to wash their genitalia after elimination) in improving toilet related quality of life for functionally impaired individuals as measured by ADLs and caregivers of functionally impaired adults. We also want to see if bidet use is effective in lowering the incidence of urinary tract infections in this high risk population.

Functional impairment around toileting has been shown to negatively impact quality of life (QOL) for both patients and their caregivers. We hope to learn if the use of bidet will improve QOL in this population.

Urinary tract infections increase the risk of morbidity and mortality in women with impaired functional status. Specifically the risk of hospitalization, sepsis, kidney failure and other complications. There are not currently effective forms of non-pharmaceutical prevention. Bidets are safe, inexpensive and hygienic. Individuals with functional impairment often have difficulty maintaining their hygiene due to frailty and functional limitations. It is our hope that addressing these issues will lead to a reduced incidence of UTI.

Constipation is a common problem in elderly adults and in adults with impaired functional status. It is our hope that the bidet will reduce the frequency and severity of constipation (as measured by self report).


Recruitment information / eligibility

Status Terminated
Enrollment 28
Est. completion date December 31, 2016
Est. primary completion date December 31, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 95 Years
Eligibility Inclusion Criteria:

Sample 1 (adults with impaired functional status):

Age: 55-95 Sex: Female Ethic background: Reflecting the population at Stanford Hospital and Clinics who meet the inclusion criteria and who agree to participate.

Sample 2 (caregivers of participants in Sample 1) Adults over the age of 21 caring for an adult with impaired functional status who has enrolled in this randomized controlled trial. Sex and ethnic background will reflect the demographic of the caregivers for the population in Sample 1.

Exclusion Criteria:

Participants not meeting the inclusion criteria.

Additional exclusion criteria:

1. Life expectancy less than 2 years

2. The inability to read and write English.

3. Patients with indwelling urinary (e.g. Foley) catheters

4. Use of any water based cleaning system after toileting at home in the past 12 months (bidet, water pot, douche etc).

5. Fully incontinent (eg diaper use)

6. Moderate to severe cognitive impairment (15 or lower on the MOCA)

Study Design


Related Conditions & MeSH terms

  • Caregiver Burden for Those Who Care for Adults With Impaired Functional Status
  • Toileting in Adults With Impaired Functional Status
  • UTI in Adults With Impaired Functional Status

Intervention

Behavioral:
Bidet use
Participants used a bidet, a device installed on the toilet that provides fresh water to help clean the bottom and genitalia after having a bowel movement or urinating.
Other:
Regular toileting
Patients in the control arm will toilet as usual.

Locations

Country Name City State
United States Stanford University School of Medicine Stanford California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improved quality of life as measured QoL questionnaire We are measuring the quality of life using a validated QoL questionnaire which has been slightly modified to include questions around toileting. 24 months
Primary Caregiver burden for caregivers of adults with functional limitations as measured by a validated caregiver burden questionnaire. We will measure caregiver burden using a validated instrument. 24 months
Secondary Incidence of UTI as measured by enquiry and chart review (female patients only). Every month we will screen female patients in both arms of the study to ask them if they have had any symptoms of UTI or sought medical attention for UTI.
We will also review their chart for diagnosis of UTI or prescription of a medication for UTI. Either self-report of a diagnosis or prescription for a medication of a UTI or a report of UTI in the chart will be considered an incidence of UTI.
24 months
Secondary Incidence of constipation as measured by self report We will ask patients on a monthly basis if they have had constipation. 24 months
Secondary Severity (measured by self report) of constipation For those patients who report having had constipation, will ask them to rate the severity of their constipation on a monthly basis. 24 months